SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-11-039501
Filing Date
2011-07-18
Accepted
2011-07-18 17:37:11
Documents
2
Group Members
DEFIANTE FARMACEUTICA S.A.PAOLO CAVAZZA

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a11-18521_1sc13da.htm SC 13D/A 130861
2 EX-21 a11-18521_1ex21.htm EX-21 17644
  Complete submission text file 0001104659-11-039501.txt   149958
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Subject) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43408 | Film No.: 11973198
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 00144 ROME ITALY
Business Address
SIGMA TAU FINANZIARIA SPA (Filed by) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231
Type: SC 13D/A